Matches in SemOpenAlex for { <https://semopenalex.org/work/W3082923610> ?p ?o ?g. }
- W3082923610 abstract "Abstract Background The Plasmodium falciparum sexual-stage surface proteins Pfs25 and Pfs230 are antigen candidates for a malaria transmission-blocking vaccine (TBV), and have been widely investigated as such. It is not clear whether simultaneously presenting these two antigens in a particulate vaccine would enhance the transmission reducing activity (TRA) of induced antibodies. To assess this, immunization was carried out with liposomes containing synthetic lipid adjuvant monophosphoryl lipid A (MPLA), and cobalt-porphyrin-phospholipid (CoPoP), which rapidly converts recombinant, his-tagged antigens into particles. Methods His-tagged, recombinant Pfs25 and Pfs230C1 were mixed with CoPoP liposomes to form a bivalent vaccine. Antigens were fluorescently labelled to infer duplex particleization serum-stability and binding kinetics using fluorescence resonance energy transfer. Mice and rabbits were immunized with individual or duplexed particleized Pfs25 and Pfs230C1, at fixed total antigen doses. The resulting antibody responses were assessed for magnitude and TRA. Results Pfs230C1 and Pfs25 rapidly bound CoPoP liposomes to form a serum-stable, bivalent particle vaccine. In mice, immunization with 5 ng of total antigen (individual antigen or duplexed) elicited functional antibodies against Pfs25 and Pfs230. Compared to immunization with the individual antigen, Pfs25 antibody production was moderately lower for the bivalent CoPoP vaccine, whereas Pfs230C1 antibody production was not impacted. All antibodies demonstrated at least 92% inhibition in oocyst density at 750 μg/mL purified mouse IgG in the standard membrane feeding assay (SMFA). At lower IgG concentrations, the bivalent vaccine did not improve TRA; antibodies induced by particleized Pfs25 alone showed stronger function in these conditions. In rabbits, immunization with a 20 µg total antigen dose with the duplexed antigens yielded similar antibody production against Pfs25 and Pfs230 compared to immunization with a 20 µg dose of individual antigens. However, no enhanced TRA was observed with duplexing. Conclusions Pfs25, Pfs230 or the duplexed combination can readily be prepared as particulate vaccines by mixing CoPoP liposomes with soluble, recombinant antigens. This approach induces potent transmission-reducing antibodies following immunization in mice and rabbits. Immunization with bivalent, particleized, Pfs230 and Pfs25 did not yield antibodies with superior TRA compared to immunization with particleized Pfs25 as a single antigen. Altogether, duplexing antigens is straightforward and effective using CoPoP liposomes, but is likely to be more useful for targeting distinct parasite life stages." @default.
- W3082923610 created "2020-09-08" @default.
- W3082923610 creator A5004070980 @default.
- W3082923610 creator A5005704874 @default.
- W3082923610 creator A5028156362 @default.
- W3082923610 creator A5039133276 @default.
- W3082923610 creator A5053266372 @default.
- W3082923610 creator A5057721546 @default.
- W3082923610 creator A5089823757 @default.
- W3082923610 creator A5090293287 @default.
- W3082923610 creator A5090902187 @default.
- W3082923610 date "2020-08-28" @default.
- W3082923610 modified "2023-10-13" @default.
- W3082923610 title "Particle-based, Pfs230 and Pfs25 immunization is effective, but not improved by duplexing at fixed total antigen dose" @default.
- W3082923610 cites W1752933373 @default.
- W3082923610 cites W1973771056 @default.
- W3082923610 cites W1986169276 @default.
- W3082923610 cites W1998160882 @default.
- W3082923610 cites W2035829098 @default.
- W3082923610 cites W2036832160 @default.
- W3082923610 cites W2074905094 @default.
- W3082923610 cites W2080689553 @default.
- W3082923610 cites W2089518061 @default.
- W3082923610 cites W2093008678 @default.
- W3082923610 cites W2100950265 @default.
- W3082923610 cites W2141913755 @default.
- W3082923610 cites W2167100631 @default.
- W3082923610 cites W2394725514 @default.
- W3082923610 cites W2440721038 @default.
- W3082923610 cites W2460575784 @default.
- W3082923610 cites W2512093981 @default.
- W3082923610 cites W2739289028 @default.
- W3082923610 cites W2793236258 @default.
- W3082923610 cites W2885422062 @default.
- W3082923610 cites W2888637796 @default.
- W3082923610 cites W2894881231 @default.
- W3082923610 cites W2917115977 @default.
- W3082923610 cites W2954428213 @default.
- W3082923610 cites W2969640204 @default.
- W3082923610 cites W2995391622 @default.
- W3082923610 cites W3011663072 @default.
- W3082923610 cites W2771053302 @default.
- W3082923610 doi "https://doi.org/10.1186/s12936-020-03368-5" @default.
- W3082923610 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7453371" @default.
- W3082923610 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32859199" @default.
- W3082923610 hasPublicationYear "2020" @default.
- W3082923610 type Work @default.
- W3082923610 sameAs 3082923610 @default.
- W3082923610 citedByCount "17" @default.
- W3082923610 countsByYear W30829236102021 @default.
- W3082923610 countsByYear W30829236102022 @default.
- W3082923610 countsByYear W30829236102023 @default.
- W3082923610 crossrefType "journal-article" @default.
- W3082923610 hasAuthorship W3082923610A5004070980 @default.
- W3082923610 hasAuthorship W3082923610A5005704874 @default.
- W3082923610 hasAuthorship W3082923610A5028156362 @default.
- W3082923610 hasAuthorship W3082923610A5039133276 @default.
- W3082923610 hasAuthorship W3082923610A5053266372 @default.
- W3082923610 hasAuthorship W3082923610A5057721546 @default.
- W3082923610 hasAuthorship W3082923610A5089823757 @default.
- W3082923610 hasAuthorship W3082923610A5090293287 @default.
- W3082923610 hasAuthorship W3082923610A5090902187 @default.
- W3082923610 hasBestOaLocation W30829236101 @default.
- W3082923610 hasConcept C147483822 @default.
- W3082923610 hasConcept C153911025 @default.
- W3082923610 hasConcept C159047783 @default.
- W3082923610 hasConcept C159654299 @default.
- W3082923610 hasConcept C178790620 @default.
- W3082923610 hasConcept C185592680 @default.
- W3082923610 hasConcept C203014093 @default.
- W3082923610 hasConcept C2776620830 @default.
- W3082923610 hasConcept C2777863537 @default.
- W3082923610 hasConcept C544153396 @default.
- W3082923610 hasConcept C86803240 @default.
- W3082923610 hasConceptScore W3082923610C147483822 @default.
- W3082923610 hasConceptScore W3082923610C153911025 @default.
- W3082923610 hasConceptScore W3082923610C159047783 @default.
- W3082923610 hasConceptScore W3082923610C159654299 @default.
- W3082923610 hasConceptScore W3082923610C178790620 @default.
- W3082923610 hasConceptScore W3082923610C185592680 @default.
- W3082923610 hasConceptScore W3082923610C203014093 @default.
- W3082923610 hasConceptScore W3082923610C2776620830 @default.
- W3082923610 hasConceptScore W3082923610C2777863537 @default.
- W3082923610 hasConceptScore W3082923610C544153396 @default.
- W3082923610 hasConceptScore W3082923610C86803240 @default.
- W3082923610 hasFunder F4320332161 @default.
- W3082923610 hasIssue "1" @default.
- W3082923610 hasLocation W30829236101 @default.
- W3082923610 hasLocation W30829236102 @default.
- W3082923610 hasOpenAccess W3082923610 @default.
- W3082923610 hasPrimaryLocation W30829236101 @default.
- W3082923610 hasRelatedWork W1539989077 @default.
- W3082923610 hasRelatedWork W1674135449 @default.
- W3082923610 hasRelatedWork W2040191638 @default.
- W3082923610 hasRelatedWork W2061622709 @default.
- W3082923610 hasRelatedWork W2072712054 @default.
- W3082923610 hasRelatedWork W2089325017 @default.
- W3082923610 hasRelatedWork W234429444 @default.
- W3082923610 hasRelatedWork W2414582544 @default.
- W3082923610 hasRelatedWork W2526461694 @default.